Influenza A Virus (IVA) H1N1 Peptide – an advanced peptide designed using the PeptAIm platform, an innovative tool powered by machine learning (ML) and artificial intelligence (AI). The algorithm has been experimentally validated, ensuring high accuracy and reliability in sequence selection.
This product is intended for cutting-edge scientific research, including molecular biology, immunology, and the development of novel therapeutic and diagnostic solutions. By leveraging AI/ML optimization, the peptide offers enhanced properties, supporting innovation in virology and beyond.
